To improve the performance of your products and to provide greater benefits for your business, we constantly strive to create breakthrough technologies. To boost our innovation process we actively exploit venturing and licensing opportunities, setting up business models that are typical of knowledge-based rather than production-based businesses, including the licensing of intellectual property. Through DSM Venturing, we have equity stakes in several start-ups focusing on key areas of the biomedical market. These include:

Harland Medical Systems , Inc.:
Markets technologies and solutions in medical coating applications

Accelerated Techologies II, L.P. (ATP):
New business incubator in the field of medical devices, with focus on cardiovascular and age related diseases

Xylos Corporation:
Actively in healthcare products based on biosynthesized cellulose. Application areas are advanced wound dressings, surgical repair products and tissue engineering

BioMedical Materials Program
We are a lead partner in the BioMedical Materials Program (BMM), a public-private partnership in the Netherlands that focuses on research and development in the field of biomedical materials. The BMM Program is an initiative of leading industrial players and universities within the Netherlands. In 2007, the Dutch government announced that it would provide EUR 45 million funding to this consortium. The program has a provisional budget of EUR 90 million and will run for five years.